
Covalon Investor Relations Material
Latest events

Q2 2025
Covalon
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Covalon Technologies Ltd
Access all reports
Covalon Technologies Ltd. is a medical technology company that develops, manufactures, and markets advanced wound care products, infection prevention solutions, and medical devices. The company's product offerings include antimicrobial dressings, collagen-based wound care products, and adhesive technologies designed to reduce infections and improve patient outcomes. Covalon serves healthcare providers, hospitals, and long-term care facilities, with a focus on providing solutions that promote faster healing and reduce the risk of complications in patients. The company operates primarily in North America and internationally, addressing the needs of the healthcare and medical device industries. The company is headquartered in Mississauga, Ontario, Canada, and its shares are listed on the TSX.
Key slides for Covalon Technologies Ltd


Q3 2024
Covalon Technologies Ltd


Q1 2025
Covalon Technologies Ltd
Latest articles
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
)
Novo Nordisk: Tipping the Scale of Innovation
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces
8 Aug 2025
)
Global Doughmination: Breaking Down Domino's Pizza
Inside the rise of Domino's Pizza: how franchising, delivery control, and supply chain mastery built one of the world's most efficient food empires.
18 Jul 2025
Ticker symbol
COV
Country
🇨🇦 Canada